Lower riskDrug recall · FDA · Published December 3, 2021
Gilead Veklury injection recall: Glass particles in vials
Gilead Sciences recalls Veklury (remdesivir) 100mg vials due to glass particles found in some batches. This could cause injury if injected. Affected vials have specific lot numbers and expiration dates.
“Gilead Veklury injection recall: Glass particles in vials.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35498-gilead-veklury-injection-recall-glass-particles-in-vials. Based on FDA recall #D-0299-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0299-2022%22&limit=1).
The FDA announced on December 3, 2021, that Gilead Sciences is recalling Veklury (remdesivir) for injection due to the presence of glass particulates. The agency classified the Class I recall as voluntary and initiated by the firm.
How to tell if you have it
Brand: Gilead Sciences
Product: Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial
NDC: 61958-2901-2
Lots: 2141001-1A, 2141002-1A
Expiration Date: 01/2024
Quantity: 53,473 vials
The hazard
An investigation into a customer complaint confirmed the presence of glass particulates in the product. The FDA classified this as a Class I recall, indicating a high risk of serious adverse health consequences or death.
Context
GovInfoNow's records show Gilead Sciences has six other recalls on file since January 31, 2013. On September 19, 2024, the company issued another recall for Veklury injection due to glass particles risk. Other recent recalls of similar products include Fresenius Kabi Tyenne Injection Recall (August 10, 2026), Mallinckrodt Acthar Gel 5mL Vial Recall (August 6, 2026), and Sun Pharmaceutical DOXOrubin Liposome Injection Recall (May 12, 2026).
How to tell if you have this one
Check the vial label for the lot numbers 2141001-1A or 2141002-1A and expiration date of January 2024. The product is a 100 mg/vial injection for medical use only.
Brand
Gilead Sciences
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Vial Label
Look for lot numbers 2141001-1A or 2141002-1A and expiration date of January 2024 on the vial.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 8 months after the firm started it.
1Firm started the recall
2FDA classified it Class I
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0299-2022 (December 3, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0299-2022 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.